Ofran Oral Solution - (4mg/5ml)

Generic Name: Ondansetron

Strength: 4mg/5ml

Presentation: Oral Solution

Indications:

• Prevention of nausea and vomiting associated with:

  • Chemotherapy

  • Radiotherapy

  • Postoperative nausea and vomiting (PONV)

Dosage and Administration:

Dosage and administration vary depending on the specific use and patient age. Here are some general guidelines:

• Chemotherapy-induced nausea and vomiting (CINV):

  • Adults: 8 mg orally, 3 times a day.

  • Children: The dose is determined by the child's weight or body surface area.

• Radiotherapy-induced nausea and vomiting (RINV):

  • Adults: 8mg orally 3 times a day.

• Postoperative nausea and vomiting (PONV):

  • Adults: 16 mg orally, 1 hour before anesthesia.

  • Specific dosing adjustments are needed for patients with hepatic impairment.

  • Consult a healthcare professional for precise dosage instructions, especially for children and those with specific medical conditions.

Side Effects:

• Common:

  • Headache

  • Constipation

  • Diarrhea

  • Fever

• Less Common:

  • Dizziness

  • Drowsiness

  • Fatigue

• Rare:

  • Arrhythmias

  • Hypotension

  • Hypersensitivity reactions (rash, itching, swelling)

  • Seizures

Precautions:

• Use with caution in patients with:

  • Liver problems

  • Heart conditions (e.g., prolonged QT interval)

  • Electrolyte imbalances

• Ondansetron may mask symptoms of ileus or gastric outlet obstruction.

• Monitor ECG in patients with congenital long QT syndrome.

Contraindications:

• Hypersensitivity to ondansetron or other serotonin 5-HT3 receptor antagonists.

• Concomitant use with apomorphine.

Use in Pregnancy & Lactation:

• Pregnancy: Ondansetron should be used during pregnancy only if the potential benefit outweighs the risk to the fetus.

• Lactation: Ondansetron is excreted in breast milk. A decision should be made whether to discontinue nursing or the drug, considering the importance of the drug to the mother.